Skip to main content
Clinical Trials/NCT00954499
NCT00954499CompletedNot Applicable

Reducing Pain in Four- to Six-month Old Infants Undergoing Immunization Using a Multi-modal Approach

Women's College Hospital1 site in 1 country120 target enrollmentStarted: July 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
120
Locations
1
Primary Endpoint
Pain response to immunization, as measured by the Modified Behavioral Pain Scale (MBPS).

Study Overview

Brief Summary

The aim of this study is to answer the following question: In healthy infants aged four to six months undergoing routine immunization for diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type B (DTaP-IPV-Hib) and pneumococcal conjugate vaccine (PCV) while receiving a combination of proven analgesic interventions (least painful injection technique, holding by parent, and oral sucrose solution) and non-procedural talk by the parent, does the addition of rubbing near the site of injection reduce pain as measured by the Modified Behavioral Pain Scale (MBPS) to a greater extent than no rubbing?

Detailed Description

Immunization is a significant source of pain and distress for infants. At present pain-relieving interventions are rarely employed to manage this pain.

There are many non-pharmacological methods that can be used to reduce immunization pain. These include: sugar water, fast injection without aspiration, holding infants during the procedure, and non-procedural related parental behaviours such as distraction. At present, there are no studies of tactile stimulation during noxious procedures in infants and its effectiveness, therefore, is unclear. Light rubbing of the skin near the injection site that is administered by a parent immediately before, during and immediately after immunization is an easily learned, cost neutral intervention that could offer improved pain management.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Care Provider)

Eligibility Criteria

Ages
4 Months to 6 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •healthy infants
  • •4 to 6 months old
  • •routine immunization with DTaP-IPV-Hib and PCV

Exclusion Criteria

  • •impaired neurological development
  • •history of seizure
  • •use of topical local anaesthetics at the injection site
  • •use of sedatives or narcotics in the preceding 24 hours
  • •fever or illness that would prevent administration of the vaccine
  • •parent is unable to use the assessment tools in the study
  • •parent does not speak English
  • •prior participation in this trial

Arms & Interventions

Standard care

Active Comparator

Intervention: Standard care (Behavioral)

Tactile stimulation

Experimental

Intervention: Tactile stimulation added to Standard care (Behavioral)

Outcomes

Primary Outcomes

Pain response to immunization, as measured by the Modified Behavioral Pain Scale (MBPS).

Time Frame: at time of injection on day 1

Secondary Outcomes

  • Pain response to immunization as measured by observer Visual Analogue Scale (VAS).(at time of injection on day 1)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials